海外の治験の状況「1」での検索結果
1495件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not recruiting
- Vitamin B2 use prior to cystoscopy
- cystoscopy;Gynaecologic surgery
- New Zealand
- 2016-10-04
Not Recruiting
- International Protocol for the Treatment of Childhood Anaplastic Large Cell Lymphoma
- Lymphoma;C84.6 - Anaplastic large cell lymphoma, ALK-positive
- Austria, Belgium, France, Germany, Italy, Netherlands, Spain, Sweden, Switzerland, United Kingdom
- 2012-04-30
Authorised
- A Phase 1/2 study to test how effective different doses of MEDI-551 is for treating subjects with Relapsing-Remitting Multiple Sclerosis
- Relapsing-Remitting Multiple Sclerosis MedDRA version: 14.1 Level: PT Classification code 10063399 Term: Relapsing-remitting multiple sclerosis System Organ Class: 10029205 - Nervous system disorders ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Austria, Canada, Czech Republic, Denmark, France, Germany, Hungary, Ireland, Israel, Italy, Netherlands, Poland, Russian Federation, Spain, Sweden, Switzerland, Turkey, Ukraine, United Kingdom, United States
- 2012-03-05
Not recruiting
- Study of Paliperidone Palmitate 3 Month and 1 Month Formulations for the Treatment of Patients With Schizophrenia
- Schizophrenia;Schizophrenia;Schizophrenia;Schizophrenia
- Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, China, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Japan, Korea, Republic of, Luxembourg, Mexico, Netherlands, Poland, Portugal, Romania, Russian Federation, Slovakia, Spain, Sweden, Taiwan, Ukraine, United States
- 2012-01-17
Not Recruiting
- Comparison of LY900014 to Insulin Lispro in Adults with Type 1 Diabetes
- Type 1 diabetes mellitus without complications
- Argentina, Australia, Austria, Brazil, Germany, Greece, India, Italy, Japan, Mexico, New Zealand, Poland, Romania, Russian Federation, Slovakia, Spain, Sweden, Taiwan, United States of America
- 2017-09-01
Recruiting
- Phase 1 Study of CK-301 as a Single Agent in Subjects With Advanced Cancers
- Lung Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Small Cell;Malignant Mesothelioma, Advanced;Head and Neck Cancer;Melanoma;Merkel Cell Carcinoma;Renal Cell Carcinoma;Urothelial Carcinoma;Classical Hodgkin Lymphoma;Colorectal Cancer;Cutaneous Squamous Cell Carcinoma;Non Hodgkin Lymphoma;Endometrial Cancer
- Australia, New Zealand, Poland, Russian Federation, Thailand
- 2017-07-06
Recruiting
- An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
- Ulcerative Colitis
- Argentina, Australia, Austria, Belgium, Brazil, Canada, Croatia, Czechia, Denmark, France, Germany, Hungary, India, Ireland, Israel, Italy, Japan, Korea, Republic of, Latvia, Lithuania, Malaysia, Mexico, Netherlands, Poland, Romania, Russian Federation, Serbia, Slovakia, Spain, Switzerland, Taiwan, Turkey, Ukraine, United Kingdom, United States
- 2018-05-04
Not Recruiting
- Tolerability , PK/PD and safety of dabigatran etexilate oral liquid formulation in children 1 year of age
- venous thrombotic event MedDRA version: 17.1 Level: LLT Classification code 10066899 Term: Venous thromboembolism System Organ Class: 100000004866 ;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
- Austria, Canada, France, Italy, Singapore, United States
- 2014-07-02
Recruiting
- Accelerated Corneal Cross-linking With Different Riboflavin Solutions
- Keratoconus;Keratoconus;Keratoconus;Keratoconus
- Austria
- 2017-06-12
Recruiting
- A Phase 1 Study of INCMGA00012 in Patients With Advanced Solid Tumors
- Locally Advanced Solid Tumors;Metastatic Solid Tumors
- Australia, Bulgaria, Germany, New Zealand, Poland, Spain, Ukraine, United Kingdom, United States
- 2017-02-09